有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | tert-butyl N-[(2S)-2,3-dimethyl-2-[(2-phenylsulfanylacetyl)amino]butyl]carbamate | —— | C19H30N2O3S |
|
—— | tert-butyl N-[(2R)-2,3-dimethyl-2-[(2-phenylsulfanylacetyl)amino]butyl]carbamate | —— | C19H30N2O3S |
|
—— | N-[(2S)-2-(furan-2-yl)-2-hydroxyethyl]-2-(2-methylphenyl)sulfanylacetamide | —— | C15H17NO3S |
|
—— | 4-[(5S)-5-(pyridin-2-ylsulfanylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C13H17N3OS2 |
|
—— | 4-methoxy-3,5-dimethyl-2-[[1-[[(2S)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylmethyl]pyridine | —— | C15H21N5O2S |
|
—— | 4-[(5S)-5-[(1-methylimidazol-2-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C12H18N4OS2 |
|
—— | 3-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-4-[[(2R)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C16H22N4O3S |
|
—— | 4-methoxy-3,5-dimethyl-2-[[1-[[(2R)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylmethyl]pyridine | —— | C15H21N5O2S |
|
—— | 4-[(5S)-5-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C11H17N5OS2 |
|
—— | 5-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]-1,3,4-thiadiazol-2-amine | —— | C16H22N4O2S2 |
|
—— | 4-[(5R)-5-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C11H17N5OS2 |
|
—— | 4-[(5S)-5-[(5-cyclopropyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C16H23N5OS2 |
|
—— | 4-[(5R)-5-[(5-cyclopropyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C16H23N5OS2 |
|
—— | 3-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C16H22N4O3S |
|
—— | 4-[(5R)-5-[(1-methylimidazol-2-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C12H18N4OS2 |
|
—— | N-[(2R)-2-(furan-2-yl)-2-hydroxyethyl]-2-(2-methylphenyl)sulfanylacetamide | —— | C15H17NO3S |
|
—— | 4-[(5R)-5-(pyridin-2-ylsulfanylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C13H17N3OS2 |
|
—— | 4-[(5S)-5-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C16H18N4O2S2 |
|
—— | 4-[(5R)-5-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C14H21N5OS2 |
|
—— | 4-[(5R)-5-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C16H18N4O2S2 |
|
—— | 4-[(5S)-5-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanylmethyl]-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C14H21N5OS2 |
|
—— | 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C20H23N3O2S |
|
—— | 5-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-N-[[(2R)-oxolan-2-yl]methyl]-1,3,4-thiadiazol-2-amine | —— | C16H22N4O2S2 |
|
—— | 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C20H23N3O2S |
|
—— | (6R)-2,2,6-trimethyl-N-[4-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]phenyl]morpholine-4-carboxamide | —— | C18H23N3O2S2 |
|
—— | (2R)-2-[(E)-but-2-enyl]sulfonyl-N-prop-2-enylpropanamide | —— | C10H17NO3S |
|
—— | (2S)-2-[(E)-but-2-enyl]sulfonyl-N-prop-2-enylpropanamide | —— | C10H17NO3S |
|
—— | N-(2-phenylsulfanylethyl)-2-(5-thiophen-3-yltetrazol-2-yl)acetamide | —— | C15H15N5OS2 |
|
—— | N-[2-(4-methylphenyl)sulfanylethyl]-2-(5-thiophen-3-yltetrazol-2-yl)acetamide | —— | C16H17N5OS2 |
|
—— | N-[2-[(2S)-2-ethylpiperidin-1-yl]ethyl]-2-phenylsulfanylacetamide | —— | C17H26N2OS |
|
—— | 3-(2-chlorophenyl)sulfanyl-N-[(2R)-1-ethylsulfonylpropan-2-yl]propanamide | —— | C14H20ClNO3S2 |
|
—— | N-[2-[(2R)-2-ethylpiperidin-1-yl]ethyl]-2-phenylsulfanylacetamide | —— | C17H26N2OS |
|
—— | 3-(2-chlorophenyl)sulfanyl-N-[(2S)-1-ethylsulfonylpropan-2-yl]propanamide | —— | C14H20ClNO3S2 |
|
—— | 2-cyclohexyl-5-[(3-propyl-1,2,4-oxadiazol-5-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C14H20N4O2S |
|
—— | 1-[(2R)-2-[(4-methylphenyl)methyl]pyrrolidin-1-yl]-2-phenylsulfanylethanone | —— | C20H23NOS |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-1-[(2R)-2-[(4-methylphenyl)methyl]pyrrolidin-1-yl]ethanone | —— | C20H21F2NOS |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-1-[(2S)-2-[(4-methylphenyl)methyl]pyrrolidin-1-yl]ethanone | —— | C20H21F2NOS |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-N-[(2S)-1-ethylsulfonylpropan-2-yl]acetamide | —— | C13H17F2NO3S2 |
|
—— | 1-[(2S)-2-[(4-methylphenyl)methyl]pyrrolidin-1-yl]-2-phenylsulfanylethanone | —— | C20H23NOS |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-N-[(2R)-1-ethylsulfonylpropan-2-yl]acetamide | —— | C13H17F2NO3S2 |
|
—— | N-[(2R)-1-ethylsulfonylpropan-2-yl]adamantane-1-carboxamide | —— | C16H27NO3S |
|
—— | N-[(2S)-1-ethylsulfonylpropan-2-yl]adamantane-1-carboxamide | —— | C16H27NO3S |
|
—— | N-[(2S)-1-methylsulfonylpropan-2-yl]adamantane-1-carboxamide | —— | C15H25NO3S |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-N-[(2R)-1-methylsulfonylpropan-2-yl]acetamide | —— | C12H15F2NO3S2 |
|
—— | N-[(2R)-1-methylsulfonylpropan-2-yl]-2-phenylsulfanylacetamide | —— | C12H17NO3S2 |
|
—— | N-[(2S)-1-methylsulfonylpropan-2-yl]-2-phenylsulfanylacetamide | —— | C12H17NO3S2 |
|
—— | N-[(2R)-1-methylsulfonylpropan-2-yl]adamantane-1-carboxamide | —— | C15H25NO3S |
|
—— | 2-(3,4-difluorophenyl)sulfanyl-N-[(2S)-1-methylsulfonylpropan-2-yl]acetamide | —— | C12H15F2NO3S2 |
|
—— | N-cyclopropyl-2-(3,4-difluorophenyl)sulfanyl-N-[(2R)-1-methylsulfonylpropan-2-yl]acetamide | —— | C15H19F2NO3S2 |
|
—— | N-cyclopropyl-2-(3,4-difluorophenyl)sulfanyl-N-[(2S)-1-methylsulfonylpropan-2-yl]acetamide | —— | C15H19F2NO3S2 |
|